Cachexia assessed by bioimpedance vector analysis as a prognostic indicator in chronic stable heart failure patients

Nutrition

Volumn 28, Issue 9, 2012, Pages 886-891

  Castillo Martínez, Lilia ^a   Colín Ramírez, Eloisa ^a   Orea Tejeda, Arturo ^a   González Islas, Dulce Gabriela ^a   Rodríguez García, Wendy Daniella ^a   Santillán Díaz, Cira ^a   Gutiérrez Rodríguez, Ana Elizabeth ^a   Vázquez Durán, Marisela ^a   Keirns Davies, Candace ^b  

^a INSTITUTO NACIONAL DE CIENCIAS MÉDICAS Y NUTRICIÓN SALVADOR ZUBIRÁN   (Mexico)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

Bioelectrical impedance vector analysis; Cachexia; Heart failure

Indexed keywords

ALBUMIN; ALDOSTERONE ANTAGONIST; ALDOSTERONE RECEPTOR ANTAGONIST; ANGIOTENSIN 2 RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CHOLESTEROL; CREATININE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; LOOP DIURETIC AGENT; NITRATE; THIAZIDE DIURETIC AGENT; TRIACYLGLYCEROL; UNCLASSIFIED DRUG;

ADULT; ALBUMIN BLOOD LEVEL; ANEMIA; ANOREXIA; ANTHROPOMETRY; ARM CIRCUMFERENCE; ARTICLE; BIOCHEMISTRY; BIOELECTRICAL IMPEDANCE VECTOR ANALYSIS; BODY MASS; CACHEXIA; CARDIAC PATIENT; CHOLESTEROL BLOOD LEVEL; CHRONIC STABLE HEART FAILURE; CLINICAL ASSESSMENT; CLINICAL ASSESSMENT TOOL; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DISEASE CLASSIFICATION; DISEASE SEVERITY; EDEMA; FEMALE; FOLLOW UP; GRIP STRENGTH; HEART EJECTION FRACTION; HEART FAILURE; HEIGHT; HUMAN; HYPOALBUMINEMIA; IMPEDANCE; MAJOR CLINICAL STUDY; MALE; MORTALITY; MUSCLE STRENGTH; NAMED INVENTORIES, QUESTIONNAIRES AND RATING SCALES; NEW YORK HEART ASSOCIATION FUNCTIONAL CLASS; PRIORITY JOURNAL; PROGNOSIS; TRIACYLGLYCEROL BLOOD LEVEL; WAIST CIRCUMFERENCE; WEIGHT;

AGE FACTORS; AGED; ANEMIA; ANOREXIA; BIOLOGICAL MARKERS; BODY COMPOSITION; BODY HEIGHT; BODY MASS INDEX; CACHEXIA; CHRONIC DISEASE; EDEMA; ELECTRIC IMPEDANCE; FEMALE; FOLLOW-UP STUDIES; HAND STRENGTH; HEART FAILURE; HUMANS; HYPOALBUMINEMIA; INSULIN RESISTANCE; MALE; MIDDLE AGED; NUTRITIONAL STATUS; PREVALENCE; RISK FACTORS; THINNESS;

EID: 84864515234     PISSN: 08999007     EISSN: 18731244     Source Type: Journal    
DOI: 10.1016/j.nut.2011.11.024     Document Type: Article

References (27)

1. Dickstein K., Cohen-Solal A., Filippatos G., McMurray J.J., Ponikowski P., Poole-Wilson P.A., et al. ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM). Eur Heart J 2008, 29:2388-2442.
2. Evans W.J., Morley J.E., Argile's J., Bales C., Baracos V., Guttridge D., et al. Cachexia: a new definition. Clin Nutr 2008, 27:793-799.
3. Muscaritoli M., Anker S.D., Argilés J., Aversa Z., Bauer J.M., Biolo G., et al. Consensus definition of sarcopenia, cachexia and pre-cachexia: Joint document elaborated by Special Interest Groups (SIG) " Cachexia-anorexia in chronic wasting diseases" and " Nutrition in geriatrics" Clin Nutr 2010, 29:154-159.
4. Kyle U.G., Bosaeus I., De Lorenzo A.D., Deurenberg P., Elia M., Gómez J.M., et al. Bioelectrical impedance analysis--part I: review of principles and methods. Clin Nutr 2004, 23:1226-1243.
5. Kyle U.G., Bosaeus I., De Lorenzo A.D., Deurenberg P., Elia M., Gómez J.M., et al. Bioelectrical impedance analysis-part II: utilization in clinical practice. Clin Nutr 2004, 23:1430-1453.
6. Piccoli A., Nescolarde L.D., Rosell J. Análisis convencional y vectorial de bioimpedancia en la práctica clínica. Nefrología 2002, 22:228-238.
7. Piccoli A., Rossi B., Pillon L., Bucciante G. A new method for monitoring body fluid variation by bioimpedance analysis: The RXc graph. Kidney Int 1994, 46:534-539.
8. Toso S., Piccoli A., Gusella M., Menon D., Crepaldi G., Bononi A., et al. Bioimpedance vector pattern in cancer patients without disease versus locally advanced or disseminated disease. Nutrition 2003, 19:510-514.
9. Piccoli A., Pillon L., Dumler F. Impedance vector distribution by sex, race, body mass index, and age in the United States: standard reference intervals as bivariate Z scores. Nutrition 2002, 18:153-167.
10. Parrinello G., Paterna S., Di Pasquale P., Torres D., Fatta A., Mezzero M., et al. The usefulness of bioelectrical impedance analysis in differentiating dyspnea due to decompensated heart failure. J Cardiac Fail 2008, 14:676-686.
11. Lohman T.G., Roche A.F., Martorell R. Anthropometric standardization reference manual 1991, Human Kinetics, Champaign, IL.
12. Rantanen T., Guralnik J.M., Foley D., Masaki K., Leveille S., Curb J.D., et al. Midlife hand grip strength as a predictor of old age disability. JAMA 1999, 281:558-560.
13. Lukaski H.C., Johnson P.E., Bolonchuk W.W., Lykken G.I. Assessment of fat-free mass using bioelectrical impedance measurements of the human body. Am J Clin Nutr 1985, 41:810-817.
14. Espinosa M.A., Rivas L., González E.C., Atilano X., Miranda P., Correa-Rolter R. Vectores de impedancia bioeléctrica para la composición corporal en población mexicana. Rev Invest Clin 2007, 59:15-24.
15. Piccoli A, Pastori G. BIVA Software. Department of Medical and Surgical Sciences; Padova, Italy: University of Padova; 2002. Available at: mailto:apiccoli@inipd.it.
16. Thomas D.R. Loss of skeletal muscle mass in aging: Examining the relationship of starvation, sarcopenia and cachexia. Clin Nutr 2007, 26:389-399.
17. Norman K., Ch Smoliner, Kilbert A., Valentini L., Lochs Pirlich M Disease-related malnutrition but not underweight by BMI is reflected by disturbed electric tissue properties in the bioelectrical impedance vector analysis. Br J Nutr 2008, 100:590-595.
18. Norman K., Pirlich M., Sorensen J., Christensen P., Kemps M., Schütz T., et al. Bioimpedance vector analysis as a measure of muscle function. Clin Nutr 2009, 28:78-82.
19. Anker S.D., Ponikowski P., Varney S., Chua T.P., Clark A.L., Webb-Peploe K.M., et al. Wasting as independent risk factor for mortality in chronic heart failure. Lancet 1997, 349:1050-1053.
20. Anker S.D., Negassa A., Coats A.J., Afzal R., Poole-Wilson P.A., Cohn J.N., Yusuf S. Prognostic importance of weight loss in chronic heart failure and the effect of treatment with angiotensin-converting-enzyme inhibitors: an observational study. Lancet 2003, 361:1077-1083.
21. Araújo J.P., Lourenço P., Rocha-Gonçalves F., Ferreira A., Bettencourt P. Nutritional markers and prognosis in cardiac cachexia. Int J Cardiol 2011, 146:359-363.
22. von Haehling S., Lainscak M., Springer J., Anker S.D. Cardiac cachexia: a systematic overview. Pharmacol Therapeut 2009, 121:227-252.
23. Piccoli A. Identification of operational clues to dry weight prescription in hemodialysis using bioimpedance vector analysis. Kidney Int 1998, 53:1036-1043.
24. Smith G.L., Lichtman J.H., Bracken M.B., Shlipak M.G., Phillips C.O., DiCapua P., et al. Renal impairment and outcomes in heart failure: Systematic review and meta-analysis. J Am Coll Cardiol 2006, 47:1987-1996.
25. Gosker H.R., Lencer N.H., Franssen F.M., van der Vusse G.J., Wouters E.F., Schols A.M. Striking similarities in systemic factors contributing to decreased exercise capacity in patients with severe chronic heart failure or COPD. Chest 2003, 123:1416-1424.
26. Raguso C.A., Ch Luthy Nutritional status in chronic obstructive pulmonary disease: Role of hypoxia. Nutrition 2011, 27:138-143.
27. Nakaya Y., Shimohata T., Haraguchi S., Nakao T., Minaguchi J., Sumitani H., et al. Severe catabolic state after an overnight fast in patients with chronic renal failure. Nutrition 2011, 27:329-332.